对于神经发育障碍儿童失眠的电子健康计划 (更好的夜晚,更好的日子):随机对照试验经济评估协议
Xiao Yang Jia1, Pantelis Andreou2, Cary Brown3
1The School of Public Policy, University of Calgary, Calgary, AB, Canada.
JMIR research protocols
|September 12, 2023
概括
本研究评估了"神经发育障碍儿童更好的夜晚,更好的日子" (BNBD-NDD) 电子健康干预措施改善神经发育障碍儿童睡眠的成本效益.
科学领域:
- 儿科睡眠医学 儿科睡眠医学
- 卫生经济学 卫生经济学
- 数字健康干预措施 数字健康干预措施
背景情况:
- 患有神经发育障碍的儿童经常患有失眠症,这会影响他们的健康和照顾者的健康.
- 建议行为干预作为儿科失眠的第一线治疗.
- 神经发育障碍儿童的更好的夜晚,更好的日子 (BNBD-NDD) 是一个由家长提供的电子健康干预措施,针对具有特定神经发育条件的儿童 (4-12岁) 失眠.
研究的目的:
- 在BNBD-NDD干预的随机对照试验 (RCT) 旁边进行经济评估.
- 与通常护理相比,评估BNBD-NDD的成本,有效性和成本效益.
- 为了确定BNBD-NDD对服务不足的人口的值.
主要方法:
- BNBD-NDD RCT将父母随机分为干预或常规护理,评估对儿童睡眠,生活质量 (儿科生活质量清单 [PedsQL]) 和父母功能的影响.
- 进行了经济评估,收集了基线和8个月的数据.
- 从家庭付款人和社会角度进行了成本效益和成本后果分析,分别在8个月的时间内进行.
主要成果:
- 获得了资金,并在2015年和2019/2022年获得了道德批准.
- 对RCT的数据收集发生在2019年6月至2022年4月之间.
- 目前正在进行RCT和并发经济评估的数据分析.
结论:
- 这是针对神经发育障碍儿童失眠的电子健康干预措施的首次经济评估.
- 调查结果将为利益相关者提供关于BNBD-NDD干预的成本和收益的信息.
- 研究协议概述了一种严格的方法来评估可扩展的数字健康解决方案.
相关概念视频
Blind Procedures
10.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.7K
Management of Insomnia
278
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
278
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K


